Sign inJoin waitlistJoin the waitlist

Valerie Baker

Director, Stanford Reproductive Endocrinology and Infertility Program · Stanford Health Care

Credentials: · · · ·

History

Johns Hopkins School of Medicine
2019–Present

Reproductive Endocrinology and Infertility
1994–1997
Obstetrics and Gynecology
1990–1994
Harvard Medical School
1984–1988

Research

Letrozole versus clomiphene for infertility in the polycystic ovary syndrome
New England Journal of Medicine · 2014 · 436 citations
Increased Preeclampsia Risk and Reduced Aortic Compliance With In Vitro Fertilization Cycles in the Absence of a Corpus Luteum
Hypertension · 2019 · Last of 15 authors · 274 citations
Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States
Fertility and Sterility · 2011 · 232 citations

Rebecca Usadi
17 papers
Michael Diamond
16 papers
Michael Eisenberg
16 papers
Richard Legro
16 papers
Karl Hansen
15 papers
Nanette Santoro
15 papers
Ruth Lathi
15 papers
Kurt Barnhart
14 papers
EE
Esther Eisenberg
13 papers
Ruben Alvero
13 papers
Christos Coutifaris
12 papers
GA
Geoffrey Adamson
12 papers

Grants

1/3 A Randomized Controlled Trial of Frozen Embryo Transfers Performed in Modified Natural Versus Programmed Cycles (NatPro)
National Institute of Child Health and Human Development · R01
Contact PI · $9.3M · Johns Hopkins University
2019–2026
1/4 Reproductive Medicine Collaborative Consortium: A Randomized Placebo-Controlled Trial of EGCG to Improve Fertility in Women with Uterine Fibroids
National Institute of Child Health and Human Development · R01
PI · $988.3K · Johns Hopkins University
2019–2025

Clinical trials

Correlation Between Oocyte and Embryo Mechanical Properties on Embryo Development and Clinical Pregnancy After In Vitro Fertilization
Principal investigator · Completed
Stanford University
2015–2018
Clinical Efficacy and Tolerability of Two FSH Preparations (Human FSH Versus rFSH - Follitropin Alpha) in Women Undergoing IVF
Principal investigator · Completed · Phase 3
IBSA Institut Biochimique SA
2005–2006